Search
for
Sort by
Research 601–630 of 1000+
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Extraskeletal actions of vitamin D
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- EFFECT OF "AMINOPTERIN" ON EPITHELIAL TISSUES
- Advances in the human skin microbiota and its roles in cutaneous diseases
- Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications
- Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review
- Natural killer cells in atopic and autoimmune diseases of the skin
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Antioxidants in dermatology
- The role of PPAR<i>γ</i>-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology
- Type II Keratins Are Phosphorylated on a Unique Motif during Stress and Mitosis in Tissues and Cultured Cells
- Regulated Proenkephalin Expression in Human Skin and Cultured Skin Cells
- Methotrexate in dermatology
- The importance of the neuro‐immuno‐cutaneous system on human skin equivalent design
- Insulin Resistance and Skin Diseases
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Local heroes or villains: tissue-resident memory T cells in human health and disease
- A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes<i>in vitro</i>and<i>in situ</i>
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- Perceived Stigmatization among Dermatological Outpatients Compared with Controls: An Observational Multicentre Study in 17 European Countries
- The itchy scalp - scratching for an explanation
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
- 17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes
- Immune-Epithelial Cross Talk in Regeneration and Repair
- Oral Retinoids in Dermatology
- Loss of epidermal Evi/Wls results in a phenotype resembling psoriasiform dermatitis